Human Hair Follicle-Derived Conditioned Media and Method of Making Same
Summary
USPTO published patent application US20260097082A1 covering methods for preparing hair follicle-derived conditioned media containing bioactive factors. The hair follicles are retrieved non-invasively and cultured to secrete therapeutic compounds. The application covers compositions for therapeutic and cosmetic treatments including hair restoration and skin repair.
What changed
USPTO published patent application US20260097082A1 for hair follicle-derived conditioned media and methods of making same. The application covers non-invasive retrieval of hair follicles, culturing to produce bioactive factors, and compositions for therapeutic or cosmetic treatments.
Biotechnology and cosmetics companies developing hair restoration, skin repair, or regenerative medicine products should monitor this application's prosecution. Researchers and manufacturers in these sectors may want to assess freedom-to-operate implications or explore licensing opportunities once the patent grants.
What to do next
- Monitor for patent prosecution updates
- Review for freedom-to-operate implications
- Assess potential licensing opportunities
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
HUMAN HAIR FOLLICLE-DERIVED CONDITIONED MEDIA AND METHOD OF MAKING SAME
Application US20260097082A1 Kind: A1 Apr 09, 2026
Inventors
Drew Wesley Taylor, Muneera Walid Fayyad, Amatullah Khuzaima Fatehi
Abstract
A method of preparing hair follicle-derived conditioned medium which comprises one or more bioactive factors, wherein the hair follicle is retrieved from a subject non-invasively, cultured in a culture medium for a duration sufficient for a hair follicle-derived cell to secrete the one or more bioactive factors to condition the medium. A hair follicle-derived conditioned medium comprising one or more bioactive factors secreted by a hair follicle-derived cell retrieved from a subject non-invasively. A composition comprising said conditioned medium. Use of said conditioned medium and composition for therapeutic or cosmetic treatment.
CPC Classifications
A61K 35/36 A61K 8/985 A61K 35/19 A61P 17/02 A61Q 7/00 C12N 5/0056 C12N 5/0627 C12N 5/56
Filing Date
2023-09-27
Application No.
19113090
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.